Essex Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $781K | Buy |
6,116
+345
| +6% | +$43.1K | 0.04% | 344 |
|
|
2025
Q4 | $704K | Buy |
5,771
+1,269
| +28% | +$146K | 0.04% | 362 |
|
|
2025
Q3 | $451K | Buy |
4,502
+373
| +9% | +$33.6K | 0.03% | 448 |
|
|
2025
Q2 | $342K | Buy |
4,129
+1,563
| +61% | +$125K | 0.02% | 512 |
|
|
2025
Q1 | $208K | Buy |
+2,566
| New | +$229K | 0.02% | 600 |
|
|
2024
Q4 | – | Sell |
-5,115
| Closed | -$502K | – | 662 |
|
|
2024
Q3 | $502K | Buy |
5,115
+2,568
| +101% | +$252K | 0.04% | 379 |
|
|
2024
Q2 | $242K | Buy |
2,547
+285
| +13% | +$25.6K | 0.02% | 534 |
|
|
2024
Q1 | $215K | Sell |
2,262
-2
| -0.1% | -$186 | 0.02% | 496 |
|
|
2023
Q4 | $202K | Buy |
+2,264
| New | +$168K | 0.02% | 483 |
|
|
2023
Q1 | – | Sell |
-2,689
| Closed | -$223K | – | 509 |
|
|
2022
Q4 | $223K | Sell |
2,689
-1,521
| -36% | -$123K | 0.02% | 436 |
|
|
2022
Q3 | $334K | Sell |
4,210
-228
| -5% | -$19.2K | 0.04% | 321 |
|
|
2022
Q2 | $330K | Sell |
4,438
-2,840
| -39% | -$213K | 0.04% | 337 |
|
|
2022
Q1 | $654K | Sell |
7,278
-660
| -8% | -$60.9K | 0.06% | 247 |
|
|
2021
Q4 | $889K | Buy |
7,938
+344
| +5% | +$41.5K | 0.09% | 214 |
|
|
2021
Q3 | $955K | Buy |
7,594
+432
| +6% | +$55.6K | 0.11% | 188 |
|
|
2021
Q2 | $972K | Hold |
7,162
| – | – | 0.14% | 155 |
|
|
2021
Q1 | $972K | Buy |
7,162
+605
| +9% | +$90.6K | 0.17% | 132 |
|
|
2020
Q4 | $923K | Buy |
6,557
+2,635
| +67% | +$338K | 0.18% | 124 |
|
|
2020
Q3 | $437K | Hold |
3,922
| – | – | 0.11% | 175 |
|
|
2020
Q2 | $439K | Buy |
3,922
+27
| +0.7% | +$2.66K | 0.14% | 144 |
|
|
2020
Q1 | $302K | Buy |
+3,895
| New | +$345K | 0.11% | 180 |
|
|
2018
Q2 | – | Sell |
-16,689
| Closed | -$1.46M | – | 355 |
|
|
2018
Q1 | $1.46M | Buy |
+16,689
| New | +$1.52M | 0.29% | 99 |
|
|
2017
Q3 | – | Sell |
-13,983
| Closed | -$1.08M | – | 356 |
|
|
2017
Q2 | $1.08M | Buy |
13,983
+2,708
| +24% | +$192K | 0.23% | 109 |
|
|
2017
Q1 | $782K | Hold |
11,275
| – | – | 0.18% | 126 |
|
|
2016
Q4 | $667K | Sell |
11,275
-2,874
| -20% | -$177K | 0.14% | 147 |
|
|
2016
Q3 | $938K | Sell |
14,149
-450
| -3% | -$27.8K | 0.22% | 110 |
|
|
2016
Q2 | $790K | Sell |
14,599
-6,350
| -30% | -$348K | 0.19% | 123 |
|
|
2016
Q1 | $1.08M | Sell |
20,949
-860
| -4% | -$44.7K | 0.27% | 90 |
|
|
2015
Q4 | $1.53M | Sell |
21,809
-59
| -0.3% | -$4.02K | 0.37% | 71 |
|
|
2015
Q3 | $1.36M | Buy |
21,868
+1,888
| +9% | +$149K | 0.35% | 72 |
|
|
2015
Q2 | $1.68M | Buy |
19,980
+1,665
| +9% | +$129K | 0.43% | 61 |
|
|
2015
Q1 | $1.38M | Buy |
18,315
+3,870
| +27% | +$270K | 0.35% | 70 |
|
|
2014
Q4 | $898K | Buy |
14,445
+1,278
| +10% | +$72.9K | 0.23% | 108 |
|
|
2014
Q3 | $685K | Buy |
13,167
+1,320
| +11% | +$67.3K | 0.2% | 124 |
|
|
2014
Q2 | $608K | Buy |
11,847
+597
| +5% | +$26.9K | 0.18% | 134 |
|
|
2014
Q1 | $534K | Buy |
11,250
+6,000
| +114% | +$307K | 0.17% | 132 |
|
|
2013
Q4 | $228K | Buy |
5,250
+225
| +4% | +$9.31K | 0.08% | 244 |
|
|
2013
Q3 | $216 | Buy |
+5,025
| New | +$204K | 0.07% | 237 |
|
Other funds holding XBI
Essex Financial Services's XBI Position: Q1 2026 in Review
Essex Financial Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 6% in Q1 2026, buying an estimated $43.1K and bringing the position to 6,116 shares worth $781K. The position accounts for 0.04% of the portfolio, ranked #344.
Essex Financial Services first reported a position in XBI in Q3 2013 and has held it in 38 quarters since. The position peaked at $1.68M in Q2 2015. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Essex Financial Services held 6,116 shares of State Street SPDR S&P Biotech ETF worth $781K as of Q1 2026.
- Essex Financial Services bought 345 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $43.1K.
- State Street SPDR S&P Biotech ETF made up 0.04% of Essex Financial Services's portfolio in Q1 2026, its #344 holding.
- Essex Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and has held it in 38 quarters since.
- Essex Financial Services's State Street SPDR S&P Biotech ETF position peaked at $1.68M in Q2 2015.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.